Introduction
============

*Legionella pneumophila* is the causative agent of Legionnaires' disease, an acute form of pneumonia (Fraser et al., [@B36]). It is a common, but often underestimated, cause of community-acquired and nosocomial pneumonia. The case-fatality rate of Legionellosis ranges between 10 and 40% and may approach 50% in nosocomial outbreaks, particularly among individuals with compromised health status (Benin et al., [@B8]). In Germany, where pneumonia causes are systematically investigated, *Legionella* is a leading cause of community-acquired pneumonia (von Baum et al., [@B115]).

*Legionella pneumophila* is commonly found in almost all natural and engineered water systems where it replicates in a variety of phagocytic protozoa, including *Hartmannella vermiformis*. Transmission mechanisms are still unclear, but a clear association was found between local watershed hydrology and Legionellosis risk in Toronto (Ng et al., [@B68]), which indicates that environmental factors are key players in transmission to humans. In people, infection is thought to occur by inhalation of contaminated water droplets.

Once in the lungs, *L. pneumophila* infects and replicates inside alveolar macrophages. To successfully infect and grow inside host cells, *L. pneumophila* circumvents normal endocytic trafficking pathways and inhibits phagosome acidification and fusion with lysosomes to establish a permissive replication niche called the *Legionella* containing vacuole (LCV) (Franco et al., [@B35]). The LCV is characterized by recruitment of early secretory vesicles, mitochondria, and membrane vesicles derived from the Golgi and endoplasmic reticulum (Roy and Tilney, [@B80]; Molofsky and Swanson, [@B66]; Shin and Roy, [@B90]). Central to the formation of the LCV and intracellular growth is the Icm/Dot type IVB secretion system, which translocates approximately 200 diverse effector proteins to the cytosol and LCV membrane (Segal and Shuman, [@B83]; Segal et al., [@B83]; Vogel et al., [@B114]; Cazalet et al., [@B16]; Chien et al., [@B22]; de Felipe et al., [@B27]; Burstein et al., [@B13]; Hubber and Roy, [@B48]; Faucher et al., [@B31]; Huang et al., [@B47]; Zhu et al., [@B126]).

Because *L. pneumophila* has evolved in a variety of niches, including aquatic environments, biofilms as well as within diverse hosts, different stress response pathways and virulence pathways must be correctly regulated. Although little is known about gene regulation in natural or engineered aquatic environments, several two-component systems are known to be involved in the regulation of stress response pathways and virulence factors required during host cells infection. These include PmrA/PmrB (Zusman et al., [@B127]), CpxR/CpxA (Altman and Segal, [@B2]) and LetA/LetS (Hammer et al., [@B41]). In addition, the sigma factor RpoS (σ^S^) has been shown to regulate a number of known virulence factors including many Icm/Dot effectors (Hovel-Miner et al., [@B46]) and is required for intracellular multiplication in ameba and primary macrophages but not in macrophage-like cell lines, probably because of their reduced antimicrobial capacity (Hales and Shuman, [@B40]; Abu-Zant et al., [@B1]).

There is an increased awareness of the role of small regulatory RNAs (sRNAs) in the regulation of virulence factors and other processes in bacterial pathogens (Papenfort and Vogel, [@B71]). sRNAs are short (40--500 nt) RNA molecules that typically do not encode proteins and mainly perform regulatory functions. They can originate from either primary transcripts, meaning the sRNA is transcribed from its own promoter and its transcription stops at a Rho-independent terminator, or from the processing of larger transcripts. The vast majority of sRNAs are post-transcriptional regulators that can either inhibit or enhance mRNA translation of the target mRNAs (Waters and Storz, [@B120]). Other sRNAs regulate gene expression by binding to and interfering with regulatory proteins and have global effects on gene expression. Riboswitches and untranslated regions (UTR) are not sRNA *per se*, being an intrinsic part of the mRNA, but they are often found by the methodologies used to identify small RNA molecules.

Putative sRNA molecules expressed by *L. pneumophila* were identified by both a bioinformatic approach as well as by deep RNA-sequencing from growth in broth and inside *A. castellanii* (Faucher et al., [@B30]; Weissenmayer et al., [@B121]). In addition, a number of sRNAs have been implicated in the regulation of virulence factors of *L. pneumophila*, including the CsrB homologs RsmY and RsmZ (Rasis and Segal, [@B75]; Sahr et al., [@B81]) and the RNA polymerase (RNAP) regulator 6S RNA (Faucher et al., [@B30]). This review aims to describe the current knowledge about sRNAs in general and provide a global perspective of the involvement of sRNA regulation systems in the behavior of *L. pneumophila*.

Base-Pairing sRNAs
==================

The most common type of regulatory sRNA are base-pairing sRNAs. They are short, highly structured RNA molecules that are complementary to some degree to their target mRNAs and are therefore often called antisense sRNAs (Brantl, [@B11]). Base-pairing sRNAs can have a positive or a negative effect on expression of the target gene. Binding of the sRNA at or near the ribosomal binding site (RBS) prevents recognition by the ribosome and subsequent translation (Figures [1](#F1){ref-type="fig"}B,C). Alternatively, binding of the sRNA could change the secondary structure of the mRNA and free the RBS to permit translation initiation (Figure [1](#F1){ref-type="fig"}C). sRNA-binding to the mRNA can also induce its degradation by recruiting RNases (Waters and Storz, [@B120]). Base-pairing sRNAs can be encoded in cis or in trans.

![**Mode of action of sRNAs**. **(A)** Riboswitch; **(B)** cis-encoded base-pairing sRNA; **(C)** trans-encoded base-pairing sRNA; **(D)** CsrA system; **(E)** 6S RNA. See text for details.](fmicb-02-00098-g001){#F1}

Cis-Encoded Base-Pairing sRNAs
==============================

Cis-encoded sRNAs are antisense RNA molecules encoded on the complementary strand of their target RNA gene (Figure [1](#F1){ref-type="fig"}B). Therefore, they share extensive sequence complementarity with the target mRNA but do not necessarily form long RNA duplexes (Brantl, [@B11]). Thirty-three sRNAs were recently identified in *L. pneumophila* that were at least partially complementary to genes encoding protein, some being known virulence factors (Weissenmayer et al., [@B121]; Table [1](#T1){ref-type="table"}). Lpr0020 is encoded antisense to *lpg0644*, which encodes a homolog of RtxA involved in intracellular survival and modification of trafficking (Cirillo et al., [@B24], [@B25]). Another sRNA, Lpr0050, is found antisense to the Icm/Dot effector SdeA (*lpg2157*; Bardill et al., [@B6]). Two sRNAs, Lpr0003 and Lpr0004, are antisense to the gene encoding the Icm/Dot effector LegA10, and are expressed during intracellular growth in *A. castellanii*.

###### 

**Small RNA molecules identified in *L. pneumophila***.

  Name                                            5\' end[^1^](#tfn1){ref-type="table-fn"}   3\' end[^1^](#tfn1){ref-type="table-fn"}   Size (nt)                               Regulator    Target[^5^](#tfn5){ref-type="table-fn"}   Note                                                     Reference
  ----------------------------------------------- ------------------------------------------ ------------------------------------------ --------------------------------------- ------------ ----------------------------------------- -------------------------------------------------------- --------------------------------------------------------
  **PROTEIN-BINDING sRNAs**                                                                                                                                                                                                                                                                     
  RsmY                                            7168                                       7059[^2^](#tfn2){ref-type="table-fn"}      110[^2^](#tfn2){ref-type="table-fn"}    LetA, RpoS   CsrA                                      Δ*rsmYZ* is defective for intracellular multiplication   Rasis and Segal ([@B75] ), Sahr et al. ([@B81]),
  RsmZ                                            1892720                                    1892592                                    132                                     LetA, RpoS   CsrA                                                                                               Hovel-Miner et al. ([@B46])
  6S RNA                                          951819                                     951673, 951638                             147, 182                                             RNAP                                      Required for optimal intracellular multiplication        Faucher et al. ([@B30])
  6S2 RNA                                         81013                                      80800                                      213                                                                                                                                                     Weissenmayer et al. ([@B121])
  6S2 RNA                                         80859                                      81037                                      178                                                                                                                                                     Weissenmayer et al. ([@B121])antisense
  **CIS-ENCODED BASE-PAIRING sRNAs**                                                                                                                                                                                                                                                            
  lpr0002                                         33166                                      33516                                      350                                                  lpg0027                                                                                            Weissenmayer et al. ([@B121])
  lpr0003                                         45316                                      45539                                      223                                                  lpg0038                                                                                            Weissenmayer et al. ([@B121])
  lpr0004                                         45714                                      45904                                      190                                                  lpg0038                                                                                            Weissenmayer et al. ([@B121])
  lpr0006                                         74969                                      74729                                      240                                                  lpg0066                                                                                            Weissenmayer et al. ([@B121])
  lpr0008                                         262101                                     262297                                     196                                                  lpg0228                                                                                            Weissenmayer et al. ([@B121])
  lpr0009                                         291705                                     291852                                     147                                                  lpg0245                                                                                            Weissenmayer et al. ([@B121])
  lpr0012                                         369510                                     369457                                     53                                                   lpg0320                                                                                            Weissenmayer et al. ([@B121])
  lpr0015                                         425773                                     425602                                     171                                                  lpg0384                                                                                            Weissenmayer et al. ([@B121])
  lpr0016                                         532291                                     532155                                     136                                                  lpg0494                                                                                            Weissenmayer et al. ([@B121])
  lpr0017                                         539616                                     539866                                     250                                                  lpg0499, lpg0500                                                                                   Weissenmayer et al. ([@B121])
  lpr0018                                         662203                                     662439                                     236                                                  lpg0626                                                                                            Weissenmayer et al. ([@B121])
  lpr0019                                         662451                                     663193                                     742                                                  lpg0627, lpg0628                                                                                   Weissenmayer et al. ([@B121])
  lpr0020                                         686010                                     685864                                     146                                                  lpg0644                                                                                            Weissenmayer et al. ([@B121])
  lpr0021                                         744637                                     744929                                     292                                                  lpg0691                                                                                            Weissenmayer et al. ([@B121])
  lpr0025                                         825408                                     825265                                     143                                                  lpg0754                                                                                            Weissenmayer et al. ([@B121])
  lpr0026                                         837669                                     837871                                     202                                                  lpg0766                                                                                            Weissenmayer et al. ([@B121])
  lpr0028                                         871501                                     871409                                     92                                                   lpg0796                                                                                            Weissenmayer et al. ([@B121])
  lpr0029                                         1046275                                    1046144                                    131                                                  lpg0959                                                                                            Weissenmayer et al. ([@B121])
  lpr0031                                         1135290                                    1135190                                    100                                                  lpg1035                                                                                            Weissenmayer et al. ([@B121])
  lpr0033                                         1330562                                    1330454                                    108                                                  lpg1202                                                                                            Weissenmayer et al. ([@B121])
  lpr0036                                         1385926                                    1386008                                    82                                                   lpg1259                                                                                            Weissenmayer et al. ([@B121])
  lpr0037                                         1425122                                    1425478                                    356                                                  lpg1297                                                                                            Weissenmayer et al. ([@B121])
  lpr0043                                         2040383                                    2040499                                    116                                                  lpg1821                                                                                            Weissenmayer et al. ([@B121])
  lpr0044                                         2122994                                    2122901                                    93                                                   lpg1903                                                                                            Weissenmayer et al. ([@B121])
  lpr0049                                         2389440                                    2389117                                    323                                                  lpg2142                                                                                            Weissenmayer et al. ([@B121])
  lpr0050                                         2418574                                    2418506                                    68                                                   lpg2157                                                                                            Weissenmayer et al. ([@B121])
  lpr0053                                         2564155                                    2564056                                    99                                                   lpg2261                                                                                            Weissenmayer et al. ([@B121])
  lpr0054                                         2574935                                    2574715                                    220                                                  lpg2271                                                                                            Weissenmayer et al. ([@B121])
  lpr0058                                         2867524                                    2867415                                    109                                                  lpg2535, lpg2536                                                                                   Weissenmayer et al. ([@B121])
  lpr0062                                         2948692                                    2948783                                    91                                                   lpg2612                                                                                            Weissenmayer et al. ([@B121])
  lpr0065                                         3095189                                    3095277                                    88                                                   lpg2744                                                                                            Weissenmayer et al. ([@B121])
  lpr0071                                         3351555                                    3351860                                    305                                                  lpg2961                                                                                            Weissenmayer et al. ([@B121])
  lpr0072                                         3374990                                    3375092                                    102                                                  lpg2981                                                                                            Weissenmayer et al. ([@B121])
  **TRANS-ENCODED PUTATIVE BASE-PAIRING sRNAs**                                                                                                                                                                                                                                                 
  LprA                                            2013775                                    2013510                                    265                                     RpoS, OxyR                                             Correspond to Lpr0041                                    Faucher et al. ([@B30]), Weissenmayer et al. ([@B121])
  LprB                                            2022555                                    2022672                                    117                                     OxyR                                                                                                            Faucher et al. ([@B30])
  LprC                                            978559                                     978676                                     117                                                                                                                                                     Faucher et al. ([@B30])
  LprD                                            3321618                                    3321516                                    103                                                                                                                                                     Faucher et al. ([@B30])
  LprE                                            33394003                                   33393503                                   \<50[^3^](#tfn3){ref-type="table-fn"}                                                                                                                   Faucher et al. ([@B30])
  lpr0001                                         18080                                      18214                                      134                                                                                            Functional[^6^](#tfn6){ref-type="table-fn"}              Weissenmayer et al. ([@B121])
  lpr0005                                         51416                                      51182                                      234                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0007                                         262199                                     262033                                     166                                                                                            Functional[^6^](#tfn6){ref-type="table-fn"}              Weissenmayer et al. ([@B121])
  lpr0010                                         341341                                     341434                                     93                                                                                             Very unstable                                            Weissenmayer et al. ([@B121])
  lpr0011                                         360467                                     360391                                     76                                                                                                                                                      Weissenmayer et al. ([@B121])
  lpr0013                                         411825                                     412167                                     342                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0014                                         413345                                     413495                                     150                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0022                                         753291                                     753083                                     208                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0023                                         753084                                     753379                                     295                                                                                            Functional[^6^](#tfn6){ref-type="table-fn"}              Weissenmayer et al. ([@B121])
  lpr0024                                         816705                                     816590                                     115                                                                                            Functional[^6^](#tfn6){ref-type="table-fn"}              Weissenmayer et al. ([@B121])
  lpr0027                                         861601                                     861363                                     238                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0030                                         1102961                                    1103162                                    201                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0032                                         1215340                                    1215182                                    158                                                                                            Functional[^6^](#tfn6){ref-type="table-fn"}              Weissenmayer et al. ([@B121])
  lpr0034                                         1333886                                    1334233                                    347                                                                                            Functional[^6^](#tfn6){ref-type="table-fn"}              Weissenmayer et al. ([@B121])
  lpr0035                                         1355695                                    1355444                                    251                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0038                                         1444737                                    1444509                                    228                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0039                                         1869948                                    1869698                                    250                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0040                                         2003953                                    2003691                                    262                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0042                                         2013722                                    2013773                                    51                                                                                                                                                      Weissenmayer et al. ([@B121])
  lpr0045                                         2233311                                    2233172                                    139                                                                                            Functional[^6^](#tfn6){ref-type="table-fn"}              Weissenmayer et al. ([@B121])
  lpr0046                                         2317451                                    2317603                                    152                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0047                                         2358694                                    2358599                                    95                                                                                                                                                      Weissenmayer et al. ([@B121])
  lpr0048                                         2360881                                    2360970                                    89                                                                                             Functional[^6^](#tfn6){ref-type="table-fn"}              Weissenmayer et al. ([@B121])
  lpr0051                                         2432864                                    2432952                                    88                                                                                                                                                      Weissenmayer et al. ([@B121])
  lpr0052                                         2549075                                    2548822                                    253                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0055                                         2769045                                    2768903                                    142                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0056                                         2768934                                    2769061                                    127                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0057                                         2862083                                    2862349                                    266                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0059                                         2877260                                    2877374                                    114                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0060                                         2921311                                    2921667                                    356                                                                                            Functional[^6^](#tfn6){ref-type="table-fn"}              Weissenmayer et al. ([@B121])
  lpr0061                                         2921870                                    2921081                                    789                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0063                                         2981537                                    2981411                                    126                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0064                                         3068413                                    3068327                                    86                                                                                                                                                      Weissenmayer et al. ([@B121])
  lpr0066                                         3099914                                    3099986                                    72                                                                                                                                                      Weissenmayer et al. ([@B121])
  lpr0067                                         3284621                                    3284705                                    84                                                                                                                                                      Weissenmayer et al. ([@B121])
  lpr0068                                         3294905                                    3295056                                    151                                                                                                                                                     Weissenmayer et al. ([@B121])
  lpr0069                                         3303482                                    3303401                                    81                                                                                                                                                      Weissenmayer et al. ([@B121])
  lpr0070                                         3338909                                    3338797                                    112                                                                                                                                                     Weissenmayer et al. ([@B121])
  **3**′**UTRs**                                                                                                                                                                                                                                                                                
  *lpg0165*                                       195661[^3^](#tfn3){ref-type="table-fn"}    195572[^3^](#tfn3){ref-type="table-fn"}    89                                                                                                                                                      Faucher et al. ([@B30])*--3* ′*UTR*
  infA-3′UTR                                      1976419[^3^](#tfn3){ref-type="table-fn"}   1976584[^3^](#tfn3){ref-type="table-fn"}   165                                                                                                                                                     Faucher et al. ([@B30])
  gltX-3′UTR                                      2132087[^3^](#tfn3){ref-type="table-fn"}   2131915[^3^](#tfn3){ref-type="table-fn"}   172                                                                                                                                                     Faucher et al. ([@B30])
  rpsU-3′UTR[^4^](#tfn4){ref-type="table-fn"}     2663501[^3^](#tfn3){ref-type="table-fn"}   2663567[^3^](#tfn3){ref-type="table-fn"}   66                                                                                                                                                      Faucher et al. ([@B30])
  rpsU-3′UTR[^4^](#tfn4){ref-type="table-fn"}     2663501[^3^](#tfn3){ref-type="table-fn"}   2663681[^3^](#tfn3){ref-type="table-fn"}   180                                                                                                                                                     Faucher et al. ([@B30])
  lpg2505                                         2824648[^3^](#tfn3){ref-type="table-fn"}   2824828[^3^](#tfn3){ref-type="table-fn"}   180                                                                                                                                                     Faucher et al. ([@B30])--3′UTR
  **OTHER**                                                                                                                                                                                                                                                                                     
  tmRNA                                           172820                                     173374                                     554                                                                                                                                                     Weissenmayer et al. ([@B121])
  Rnase P                                         1944961                                    1944585                                    375                                                                                                                                                     Weissenmayer et al. ([@B121])

*^1^The position of the sRNA is given relative to L. pneumophila Philadelphia-1 genome*.

*^2^The 3′ end and the size given for RsmY are based on published results in L. pneumophila Paris. In L. pneumophila Philadelphia-1, the 3′ end of RsmY is at position 7090 for a size of 79 nt, as determined by 3′ RACE*.

*^3^Estimated based on genomic sequence and size on Northern Blot. For 3′UTR, the size given is the distance between the predicted Rho-independent terminator and the stop codon of the upstream gene. The size of all 3′ UTR was higher than 500 nt as observed on northern blot*.

*^4^Two overlapping putative sRNAs were predicted in this region with distinc predicted terminators*.

*^5^For cis-encoded sRNAs, the target correspond to the gene on the complementary strand of the sRNA*.

*^6^Trans-encoded sRNAs identified by Weissenmayer et al. ([@B121]) were predicted as functional if the predicted structure was found to be stable*.

Lpr0018 is encoded antisense to *comEC* (also known as *comA*, *lpg0626*) and would form a duplex with the 5′ end of the coding sequence and partially with a putative 5′UTR. ComEC is predicted to be part of the machinery involved in DNA uptake in *L. pneumophila*. Competence for natural transformation is induced by treatment that triggers stalling of the replication fork, such as UV irradiation and exposure to bicyclomycin (Charpentier et al., [@B19]). Some evidence previously suggested that sRNA could be involved in regulation of competence in *L. pneumophila*. First, deletion of the *rnr* gene, encoding RNase R, was found to induce competence and resulted in the accumulation of small RNA molecules originating from highly structured 16S rRNA and tmRNA (see below; Charpentier et al., [@B18]). Whether or not these two phenotypes are related requires clarification. Second, the *Escherichia coli* homolog of the *L. pneumophila* competence repressor ProQ (Sexton and Vogel, [@B86]) was found to work as a RNA chaperone to allow translation of *proP* mRNA, involved in the uptake of osmoprotectants (Chaulk et al., [@B20]). Taken together, these facts could lead one to hypothesize a regulatory model in which ProQ is essential to inhibit degradation, by RNase R, of the sRNA Lpr0018, which would mediate degradation of *comEC* mRNA, similar to the mechanism depicted in Figure [1](#F1){ref-type="fig"}B. Therefore, in the absence of ProQ or RNase R, *comEC* would be stabilized and efficiently translated. Alternatively, the sRNA Lpr0018 could stabilize *comEC* mRNA, allowing its transcription, while ProQ could act as a negative regulator of Lpr0018, potentially by targeting it for degradation. However, to our knowledge, such a mechanism has yet to be described for cis-encoded sRNA. Another sRNA, Lpr0019, is 742 nt long and is complementary to the 5′ end of *lpg0627* and to the 3′ end of *lpg0628*. Both genes are part of a predicted polycistronic RNA composed of *lpg0632--lpg0627* encoding subunits of the type IV pili, which was associated with competence (Stone and Kwaik, [@B98]). Lpr0019 could possibly be involved in induction of competence in a manner similar to what we suggested for Lpr0018. Of course, those hypotheses will need to be tested experimentally. Nonetheless, the finding that two sRNAs are encoded antisense to key players of DNA uptake by *L. pneumophila* strongly suggest that its induction is regulated at the post-transcriptional level. Recently, induction of competence in *Vibrio cholerae* was found to be dependent on the expression of a trans-encoded sRNA (TfoR), which allows translation of the positive regulator TfoX (Yamamoto et al., [@B123]).

Lpr0036 is encoded antisense to *lvrA* (*lpg1259*), the first gene of the *lvr/lvh* locus encoding a Type IVA secretion system, involved in conjugation (Segal et al., [@B84]). However, the role of LvrA is currently unknown and it is difficult at this point to speculate a possible role for this sRNA.

Trans-Encoded Base-Pairing sRNAs
================================

In contrast to cis-encoded sRNA, trans-encoded base-pairing sRNAs are not physically linked to their mRNA target and the formation of RNA duplexes are mediated by short imperfect RNA interactions (Figure [1](#F1){ref-type="fig"}C). The function of many of the trans-encoded base-pairing sRNAs depends on the RNA-binding protein Hfq, which is thought to enhance the likelihood of a productive interaction between the sRNA and its target (Waters and Storz, [@B120]). This is in contrast to cis-encoded base-pairing sRNA that do not generally require the participation of a RNA chaperone (e.g., Hfq) to bind their target mRNA (Brantl, [@B11]).

In bacterial pathogens, deletion of the *hfq* gene often leads to a reduction in virulence, as was observed for *E. coli, Salmonella, Shigella, Yersinia*, and *Listeria* (Reviewed in Chao and Vogel, [@B17]). For example, in *E. coli*, Hfq was shown to regulate the locus of enterocytes effacement (LEE) encoding a type III secretion system (TTSS; Hansen and Kaper, [@B42]; Shakhnovich et al., [@B87]). In the intracellular pathogen *Salmonella enterica* serovar Typhimurium, Hfq is necessary for optimal growth in epithelial cells and macrophages (Sittka et al., [@B92]). *Burkholderia cenocepacia* encodes two Hfq homologs and both of them are required for optimal resistance to stress and virulence (Ramos et al., [@B74]). Deletion of the *hfq* gene of *Staphylococcus aureus* has no effect on metabolism but reduces virulence (Bohn et al., [@B9]; Liu et al., [@B61]). However, in *Neisseria gonorrhoeae*, deletion of *hfq* leads to only a weak reduction of virulence (Dietrich et al., [@B28]). Moreover, in some bacteria, Hfq is required for the function of some sRNAs but dispensable for others. For example, in *V. cholerae*, Hfq is required for the control of the quorum sensing systems by the sRNAs Qrr1--Qrr4, but dispensable for the repression of *ompA* by VrrA (Lenz et al., [@B58]; Song et al., [@B94]). It is noteworthy that *Helicobacter pylori* does not encode an Hfq homolog but still expresses hundreds of sRNAs (Sharma et al., [@B88]). This suggests that in some bacterial species, the function mediated by Hfq is not necessary for sRNA-mediated gene regulation or that an as yet unknown protein could carry out a similar function. Following genome-wide identification of Hfq-binding sRNAs, it was postulated that even in *E. coli*, some base-pairing sRNAs might not bind to, or use Hfq (Zhang et al., [@B125]). Careful review of the Hfq-related literature lead Jousselin et al. ([@B51]) to postulate that the need for Hfq in mRNA--sRNA interaction is related to a number of factors. First, the higher the overall GC content of the bacterial genome the more likely Hfq is required and Hfq seems to be dispensable in bacteria whose genomes display a low GC value, such as *S. aureus* (32% GC). Second, Hfq is dispensable when the sRNA--mRNA interaction is mediated by long (\>30) and uninterrupted pairing. Third, they observed a correlation between a requirement for Hfq and the C-terminal extension length of Hfq, which forms an mRNA interaction surface. Hfq proteins that have a short C-terminus tend to be found in bacteria in which Hfq is dispensable.

In *L. pneumophila*, deletion of the *hfq* gene affects the duration of the lag phase after inoculation in fresh broth (McNealy et al., [@B64]). Moreover, the *L. pneumophila* *hfq* mutant shows a reduced growth rate in chemically defined medium containing low concentrations of iron and a reduction in the expression of the ferric uptake regulator (*fur*). In *E. coli*, the RyhB sRNA negatively regulates expression of *fur* in a Hfq-dependant manner (Vecerek et al., [@B109]). In addition, the *L. pneumophila* *hfq* mutant shows a small reduction in intracellular growth (McNealy et al., [@B64]). The somewhat limited effect of deleting the *hfq* gene on *L. pneumophila* phenotypes suggests that Hfq is not critical for sRNA--mRNA interactions in this organism. The GC content of the *L. pneumophila* genome is low (38%) and alignment of its Hfq protein sequence with other homologs (Figure [2](#F2){ref-type="fig"}) reveals that the C-terminal region is short and comparable to the length of the *V. cholerae* Hfq that is not essential for all mRNA--sRNA interactions. According to the postulates of Jousselin et al. ([@B51]), one could hypothesize that Hfq will not be required for all sRNA--mRNA interactions in *L. pneumophila*.

![**Alignment of Hfq proteins from *E. coli* (Eco), *V. cholerae* (Vch), *L. pneumophila* (Lpn), and *S. aureus* (Sau) was performed with ClustalW2 (Chenna et al., [@B21])**.](fmicb-02-00098-g002){#F2}

Nonetheless, one can speculate that in *L. pneumophila*, base-pairing sRNAs acting through Hfq may regulate iron acquisition, virulence-related functions and possibly other systems as well, although Hfq function would not be essential for these. Expression profiling of a *hfq*-deficient *L. pneumophila* strain would shed light on the importance of Hfq on gene regulation and be of great help at identifying phenotypes that could be affected by it. A similar approach was used for other bacteria such as *E. coli* (Zhang et al., [@B125]), Typhimurium (Sittka et al., [@B91]), *B. cenocepacia* (Ramos et al., [@B74]), *Pseudomonas aeruginosa* (Sonnleitner et al., [@B95]), and *N. gonorrhoeae* (Dietrich et al., [@B28]). In addition, immunoprecipitation of Hfq with subsequent identification of bound sRNAs by enzymatic RNA-sequencing (Christiansen et al., [@B23]), tiling microarray (Zhang et al., [@B125]), or deep-sequencing (Sittka et al., [@B91]) would shed light on the mRNA species affected by Hfq and on the potential sRNAs whose functions are at least partially dependant on Hfq. Windbichler et al. ([@B122]) have used an affinity chromatography procedure to identify RNA-binding proteins in *E. coli*. Briefly, they tagged a number of known sRNAs with a streptomycin-binding RNA aptamer, allowing them to bind to a streptomycin-coated column, which was then used to capture RNA-binding proteins from cellular extracts. They found that three proteins were consistently bound to a variety of sRNA sequences: Hfq, RNAP β-subunit and the small ribosomal subunit S1. Moreover, they showed that specific proteins could interact with a specific sRNA, depending on its sequence and secondary structure. Therefore, a hunt for sRNA-binding proteins is necessary to complete the sRNA-mediated regulatory landscape and to fully understand the extent of their impact on regulation of cellular functions.

In *L. pneumophila*, a number of trans-encoded base-pairing sRNA candidates have been identified but mechanistic studies are needed to evaluate their mode of action and to validate them as authentic base-pairing sRNAs (Table [1](#T1){ref-type="table"}). Five intergenic RNAs were identified based on computer prediction by using the sRNA Predict software (Faucher et al., [@B30]). By searching for Rho-independent terminators in intergenic regions preceded by a sequence conserved in other *L. pneumophila* strains, 143 sRNA molecules were predicted. Using a custom-made microarray, the expression of 101 of these predicted sRNAs was monitored during growth in a variety of conditions. This two-step approach led to the identification of 12 sRNA molecules that were actively expressed, including 6S RNA, six 3′UTR, and five sRNAs that are independently transcribed (Faucher et al., [@B30]; Table [1](#T1){ref-type="table"}). At this point the functions of the five identified sRNAs are unclear. Interestingly, expression of LprA during exponential growth is dependant on OxyR but dependant on RpoS during post-exponential phase (Figure [3](#F3){ref-type="fig"}). Since RpoS is an important regulator of virulence, it is tempting to speculate that LprA could be part of its regulatory cascade and plays a role in expression of virulence factors. Regardless of the growth phase, the presence of H~2~O~2~ induces its expression, which suggests that LprA responds to oxidative stress. This is similar to the *E. coli* sRNA OxyS, which is part of the oxidative stress response and reduces its mutagenic effects (Altuvia et al., [@B3]).

![**Model of the regulatory networks involving sRNAs in *L. pneumophila***. The lines show interaction between the players: Arrow, activation; T bar, repression; dotted line, putative, or predicted interaction. See text for details.](fmicb-02-00098-g003){#F3}

RNA-sequencing identified 38 sRNA molecules encoded in intergenic regions that could be considered as potential trans-encoded sRNAs (Weissenmayer et al., [@B121]; Table [1](#T1){ref-type="table"}). Of these, nine were predicted to be functional based on the stability of their predicted secondary structures at 37°C. The predicted structure of one sRNA (Lpr0010) was less stable than 1000 randomly permutated sequences of the same length and base composition at 20 or 37°C, suggesting that it is under evolutionary pressure to form an unstable secondary structure. The biological relevance of this was not explored further, but one can hypothesize that the structure is only stable at low temperatures (less than 20°C) and that it could be part of a cellular response to low temperature. Interestingly five sRNA pairs were identified, for which two distinct sRNA are transcribed antisense to each other (Weissenmayer et al., [@B121]). In *E. coli*, the sRNAs RyeB and SraC are encoded opposite to each other and RyeB is completely complementary to the longer SraC segment (Vogel et al., [@B112]). The size of SraC is ≈270 nt, but when RyeB is present a shorter band (≈150 nt) is also detected. This reduction in size seems to be dependent on RNase III, suggesting that RyeB mediates degradation of SraC. For the sRNA pairs identified in *Legionella*, one sRNA can act as a negative regulator of the other, efficiently sequestering it by extended base-pairing and potentially targeting it for degradation. Moreover, mRNA can also regulates sRNAs. This mechanism, named trap-RNA, was described for the MicM sRNA that induces degradation of the YbfM porin mRNA. The *chb* polycistronic mRNA contain a sequence complementary to MicM and expression of the *chb* operon leads to MicM hybridization and degradation, resulting in stabilization of the *ybfM* mRNA (Figueroa-Bossi et al., [@B33]; Overgaard et al., [@B69]). Again, additional work is needed to understand the regulatory functions of *Legionella* trans-encoded base-pairing sRNA.

There are a number of base-pairing sRNAs encoded in other bacterial genomes that are known to affect virulence. A few examples are provided below that might be relevant in the context of *L. pneumophila* intracellular growth. One intracellular pathogen for which extensive identification and characterization of sRNA have been and are being performed is *Salmonella*. In this species, outer membrane protein (OMP) expression is regulated by a network of sRNAs. One of them, InvR, is encoded on the *Salmonella* pathogenicity island-1, acquired by horizontal gene transfer (HGT) and encoding the TTSS responsible for enterocyte invasion (Pfeiffer et al., [@B72]). Expression of this sRNA is dependant on HilD, a key regulator of TTSS expression. When the TTSS is expressed, InvR acts as a negative regulator of OmpD synthesis, one of the most abundant OMP in Typhimurium. Indirect evidence suggests that repression of OmpD could stabilize the membrane in the context of TTSS expression, allowing succesful translocation of bacterial effectors (Vogel, [@B111]). Therefore, InvR is thought to have helped establishment of the TTSS sequences after HGT by repressing expression of OMP that were incompatible with the virulence advantage provided by the TTSS (Vogel, [@B111]). Therefore, it is tempting to speculate that similar mechanisms exist in *L. pneumophila* to repress OMPs during expression of the Icm/Dot system, the Type IVA secretion system (*lvr/lvh*) or the Tra conjugative system. However, to date, no trans-encoded sRNAs have been identified in the vicinity of these systems, but, as described above, one cis-encoded sRNA is antisense to *lvrA* (*lpg1259*).

The sRNA VrrA of *V. cholerae* is part of the membrane stress response pathway mediated by σ^E^ and targets *ompA* mRNA, presumably to limit synthesis of OMPs (Song et al., [@B94]). Deletion of *vrrA* leads to an increase in the synthesis of outer membrane vesicles that are known to be involved in delivery of virulence factors to host cells (Mashburn-Warren and Whiteley, [@B63]). Moreover, VrrA seems to negatively regulate expression of the adhesion molecule Tcp and therefore affects intestinal colonization (Song et al., [@B94]). There is structural similarity between VrrA and LprD of *L. pneumophila* and it is tempting to speculate a role for LprD in the regulation of OMP synthesis. However, structure comparisons of trans-encoded sRNAs have been of limited help for predicting function or targets, and an experimental strategy should be taken to determine if LprD regulates OMP synthesis.

The quorum system of *V. cholerae* comprises four redundant sRNAs named Qrr1--Qrr4 and two signaling molecules, the furanosyl borate diester (AI-2) and the α-hydroxyketone Cqs (Lenz et al., [@B58]). At low cell density, the system positively regulates expression of Qrr1--Qrr4, which destabilize the mRNA of *hapR*, a negative regulator of virulence. Therefore, at low cell density, *hapR* is degraded allowing expression of virulence traits. *L. pneumophila* also possesses a putative quorum system, based solely on the presence of the α-hydroxyketone Lqs and the LqsR/LqsS two-components system (TCS) (Tiaden et al., [@B102]; Spirig et al., [@B97]). Beside the absence of AI-2 signaling in *L. pneumophila* the quorum system architecture of *L. pneumophila* and *V. cholerae* are quite similar (Tiaden et al., [@B101]). However, in *L. pneumophila* no sRNA has been implicated in this regulatory system as yet. Following RNA-sequencing, two sRNAs (Lpr0001, and Lpr0069) were found to have substantial homology both at the sequence and the secondary structure levels, which is reminiscent of the Qrr1--Qrr4 sRNAs (Weissenmayer et al., [@B121]). A search for homologous sequences throughout the genome revealed 20 more copies of these sRNAs, one (Lpr0049) being partially antisense to *lpg2142*, which encodes a putative ORF. The consensus structure of these sRNAs is a long stem--loop with two central bulges comprised of ∼25 nt and two small hairpins extruding from either side of the central stem 20 nt before the loop (Weissenmayer et al., [@B121]). Many of these sequences were found in other *Legionella* strains as well, often in the same configuration, which indicates that they are evolutionarily conserved and likely to play a beneficial role. Moreover, both the Lqs system and the homologous sRNA sequences are absent in *L. longbeachae*. These observations are only suggestive and experimental evidence is needed to link the Lqs quorum sensing system with this group of homologous sRNA sequences. It is noteworthy that deletion of all four Qrr sRNAs was needed to see a phenotype on the quorum sensing system (Lenz et al., [@B58]). Since only Lpr0001 and Lpr0069 seem to be expressed at good level, it might be informative to generate a double *lpr0001/lpr0069* mutant and monitor its effect on a population density-related phenotype.

Although the vast majority of base-pairing sRNAs do not encode proteins, there are at least two examples where they do. In *E. coli* the *sgrS* gene encodes a sRNA, SgrS, and a small protein, SgrT, that together regulate glucose uptake by different strategies (Wadler and Vanderpool, [@B116]). In *S. aureus*, the sRNA RNA III targets virulence factors and functions as a key regulator of virulence, but also encodes a 26 amino acid long hemolysin (Boisset et al., [@B10]). Therefore, one should keep in mind that sRNAs are not necessarily non-coding. We recently identified two small RNA molecules, LstA and LstB that are predicted to encode small proteins with transmembrane motifs (Faucher et al., [@B30]). Because small proteins are difficult to predict accurately from genomic sequences, the hunt for small RNA molecules also has the potential benefit of filling the gaps of genomic annotation by also identifying putative small proteins and correcting errors in genome annotation.

The CsrA/CsrB System
====================

The CsrA protein was first identified in *E. coli* as a regulator of glycogen biosynthesis (Romeo et al., [@B79]). CsrA binds to GGA motifs in the 5′UTR of target mRNAs and affects their stability and/or their translation (Romeo, [@B78]). The sRNAs CsrB and CsrC contain many GGA motifs and can therefore bind multiple CsrA proteins resulting in titration/sequestration of CsrA, thus relieving CsrA effects on the expression of its target mRNAs (Figure [1](#F1){ref-type="fig"}D). Transcription of CsrB and CsrC is regulated by the BarA/UvrY TCS. Both sRNAs are degraded by a pathway involving RNase E and CsrD, a cyclic di-GMP binding protein (Suzuki et al., [@B100]).

*Legionella pneumophila* contains four CsrA homologs, of which one (*lpg0781*) was identified as able to complement a *csrA* deletion in *E. coli* (Fettes et al., [@B32]). The roles of the other CsrA homologs are currently unknown. In *L. pneumophila*, CsrA is responsible for the repression of post-exponential traits during exponential growth, including pigmentation, motility, and cell shortening (Fettes et al., [@B32]; Molofsky and Swanson, [@B65]; Forsbach-Birk et al., [@B34]). Moreover, CsrA is required for intracellular growth in both mammalian macrophages and *A. castellanii* (Molofsky and Swanson, [@B65]; Forsbach-Birk et al., [@B34]). Recently, it was shown that CsrA directly repressed the expression of *ylfA/legC7, ylfB/legC2*, and *vipA*, which encode Icm/Dot effectors (Rasis and Segal, [@B76]). Regulation of CsrA expression seems to be dependant on PmrA, another well-known virulence regulator (Rasis and Segal,  [@B76]b).

The *L. pneumophila* genome encodes homologs of the BarA/UvrY TCS named LetA/LetS. This system was first identified as a positive regulator of flagellin expression (Hammer et al., [@B41]). Although a *letA* mutant still replicates in mammalian macrophages, it is defective for replication in *A. castellanii* (Gal-Mor and Segal, [@B37]; Lynch et al., [@B62]). Subsequently, LetA was shown to regulate expression of a number of virulence factors, including Mip, IcmR, IcmT, DotA, and the Icm/Dot effector RalF (Gal-Mor and Segal, [@B37]; Shi et al., [@B89]).

Based on these results, the consensus model is that during exponential phase, CsrA represses expression of post-exponential phase genes, either by inhibiting mRNA translation, or by modulating their stability. During post-exponential phase, the LetA/LetS TCS, supposedly by inducing expression of CsrB homologs, inhibits the activity of CsrA, allowing expression of post-exponential traits (pigmentation, cytotoxicity, and motility). Computer predictions of CsrB homologs in several bacterial species identified two candidate CsrB homologs in *L. pneumophila*, based on the identification of intergenic regions enriched for the GGA motif (Kulkarni et al., [@B54]). These two sRNAs were named RsmY and RsmZ (Table [1](#T1){ref-type="table"}), based on their short size, which more closely resemble the sRNAs involved in the RsmA (CsrA) system of *P. aeruginosa* (Lapouge et al., [@B56]). It was shown that: (i) LetA specifically binds upstream of *rsmY* and *rsmZ* and that the LetA/LetS TCS controls their expression; (ii) expression of *rsmY* and *rsmZ* in *E. coli* results in a similar phenotype as over-expression of *csrB* and *csrC* and; (iii) RsmY and RsmZ bind CsrA, confirming that RsmY and RsmZ are the missing link in the LetA/S--CsrA regulatory pathway (Hovel-Miner et al., [@B46]; Rasis and Segal, [@B76]; Sahr et al., [@B81]; Figure [1](#F1){ref-type="fig"}E). Deletion of either *rsmY* or *rsmZ* has little impact on virulence, but deletion of both strongly impaired replication in both mammalian macrophages and *A. castellanii* (Sahr et al., [@B81]). It was also shown that increased expression of *rsmY* and *rsmZ* during post-exponential phase requires RpoS, probably due to the regulation of *letS* expression by RpoS (Hovel-Miner et al., [@B46]; Rasis and Segal, [@B76]). Reduced expression of CsrA leads to an increase in *rpoS* expression, which suggests the existence of a positive feedback loop (Forsbach-Birk et al., [@B34]). However, deletion of *rsmYZ*, which should mimic over-expression of CsrA, also resulted in increased expression of *rpoS* (Sahr et al., [@B81]). Therefore, the interplay between LetS, RsmYZ, CsrA, and RpoS remains unclear and will require further investigation (Figure [3](#F3){ref-type="fig"}).

Interestingly, RpoS and LetA, two major regulators of virulence-related traits in *L. pneumophila* positively regulate expression of *hfq* during exponential growth (McNealy et al., [@B64]). Whether or not Hfq, in turn, affects RsmY and RsmZ function or stability is currently unknown (Figure [3](#F3){ref-type="fig"}). In *P. aeruginosa*, Hfq binds to and affects the stability of RsmY (Sonnleitner et al., [@B96]). Also, the LqsR/LqsS TCS is regulated by the CsrA system, which is similar to what was shown for *V. cholerae* (Lenz et al., [@B57]; Tiaden et al., [@B102]; Sahr et al., [@B81]).

Microarray studies revealed that no genes were significantly affected by the deletion of either *letA*, *letS*, or *rsmYZ* during exponential growth in rich broth, in agreement with the current working model in which CsrA is active during exponential phase and that the LetA/LetS/RsmYZ part of the regulatory cascade is silent (Sahr et al., [@B81]). However, during the post-exponential phase of growth, many genes were negatively affected by deletion of either *letA* or *letS* or both *rsmYZ*, including a number of Icm/Dot effectors (RalF, SidC, SdeA, SdeC, SidF, and SdhB) (Sahr et al., [@B81]). Independently, it was shown that RsmY and RsmZ relieve the CsrA-mediated repression of the expression of *ylfA/legC7*, *ylfB/legC2*, and *vipA* (Rasis and Segal, [@B76]). However, expression of flagellar genes was largely RsmYZ independent but negatively affected by deletion of either *letA* or *letS* (Sahr et al., [@B81]). However, since CsrA affects mRNA translation, over-expression of RsmY and RsmZ could result in a stronger phenotype at the protein level. Interestingly several genes positively affected by LetA/S and RsmYZ were predicted to encode GGDEF and/or EAL domains, including *lpg0156* (*cdgS4*) and *lpg2132* (*cdgs20*) (Sahr et al., [@B81]; Levi et al., [@B59]), suggesting that there may be crosstalk between the CsrA system and the cyclic di-GMP system (Figure [3](#F3){ref-type="fig"}) as it was shown in *E. coli* (Jonas et al., [@B50]). Interestingly, wild-type bacteria that over-express *cdgs20* are defective for intracellular multiplication (Levi et al., [@B59]).

The RNA Polymerase/6S RNA System
================================

The 6S RNA of *E. coli* was first identified and sequenced 40 years ago (Hindley, [@B44]; Brownlee, [@B12]). However, its function remained elusive until the year 2000 when Wassarman and Storz ([@B119]) showed that 6S RNA binds to the σ^70^ and the β/β′ subunits of RNAP and inhibits transcription of the *rsd* gene from its σ^70^-dependant promoter. Later, it was shown that, in laboratory *E. coli* strains, deletion of the 6S RNA gene, *ssrS*, renders cells more resistant to high pH and less able to compete against wild-type bacteria for survival in deep stationary phase (Trotochaud and Wassarman, [@B105], [@B105]).

In bacteria, functional RNAP holoenzyme consists of the core subunits β/β′α~2~ω, which associate with a σ subunit that provides promoter specificity. In *E. coli*, the σ^70^-RNAP holoenzyme (Eσ^70^) is responsible for bulk transcription during exponential phase. During stationary phase, the σ^S^ subunit preferentially associates with the β/β′α~2~ω subunits of RNAP to allow transcription of stationary phase genes. The general consensus for the role of 6S RNA\'s regulatory effect is based on its preferential binding to Eσ^70^, compared to Eσ^S^, and the observation that binding of 6S RNA to Eσ^70^ inhibits its binding to DNA promoters (Figure [1](#F1){ref-type="fig"}E). Thus, in the presence of 6S RNA, Eσ^70^ is sequestered, promoting the formation of other holoenzymes, such as Eσ^S^, that are able to activate transcription from their specific promoters (Wassarman, [@B117]). Later, it was shown that σ^70^-dependant promoters negatively affected by the presence of 6S RNA contained a weak -35 element and an extended -10 element (Cavanagh et al., [@B15]). Thus, 6S RNA may function as a competitor for the binding of Eσ^70^ to a specific subset of promoters.

Following bioinformatic prediction of sRNAs in *L. pneumophila*, one sRNA showed very high expression during the post-exponential phase of growth, similar to *E. coli* 6S RNA (Wassarman and Storz, [@B119]). Its predicted structure was highly similar to the published consensus structure of the widely distributed 6S RNA (Barrick et al., [@B7]; Trotochaud and Wassarman, [@B106]). All the previously identified conserved features of 6S RNA homologs were present in the *L. pneumophila* 6S RNA candidate, including: (i) a 22-nt closing stem with two small bulges; (ii) a central bulge composed of 14 nt on the 5′ strand and 13 nt on the 3′ strand of low %GC content; (iii) two G--C base pairs surrounding the central bulge; and (iv) a terminal loop comprising four small bulges resembling the consensus terminal loop of the γ-proteobacteria lineage of 6S RNAs. Co-immunoprecipitation studies revealed that the *L. pneumophila* 6S RNA candidate physically associate with RNAP (Faucher et al., [@B30]). Therefore, the gene encoding this sRNA was named *ssrS* in accordance with the published nomenclature recommendations (Barrick et al., [@B7]).

Deletion of the *ssrS* gene reduced intracellular growth in human macrophages and in *A. castellanii* by 10-fold despite no difference in Icm/Dot translocation activity or cytotoxicity (Faucher et al., [@B30]). Also, the 6S RNA deficient strain was unable to compete against the wild-type strain during intracellular growth but grew equally well in AYE broth. Thus, it seems that in *L. pneumophila* 6S RNA is important for optimal expression of genes related to intracellular growth (Figure [3](#F3){ref-type="fig"}). In order to further dissect the effects of 6S RNA on gene expression, microarray analysis was used to monitor global gene expression patterns during the post-exponential phase of growth, when the 6S RNA is most abundant. When the *ssrS* deletion mutant strain was compared to the wild-type it was observed that *L. pneumophila* 6S RNA negatively affects expression of six genes and promotes transcription of 127 genes during post-exponential phase of growth, including those encoding: a subset of Icm/Dot effectors (VipA, LegC5, SdeC, SdbC), small molecule transporters, DNA repair enzymes as well as genes involved in fatty acid metabolism, amino acid metabolism, and carbohydrate metabolism. This was somewhat in contradiction with the consensus understanding of 6S RNA being mainly an inhibitor of transcription from σ^70^-dependant promoters. However, a recent study revealed that 6S RNA is also an activator of transcription in *E. coli*, where it negatively affects transcription of 148 genes and positively affects expression of 125 genes (Neusser et al., [@B67]). In this study, genes affected by 6S RNA contain promoters that are specific for a variety of σ subunits, including σ^S^, σ^32^, and σ^54^. Accordingly, 6S RNA seems to bind also to Eσ^S^, although with much less affinity than for Eσ^70^ (Gildehaus et al., [@B38]). Therefore, it seems that 6S RNA regulation is not as clear-cut as first conceived and these results suggest that many variations on a common theme may exist in different bacterial species. Factors that could influence 6S RNA regulation in *L. pneumophila* include distinctive usage of the different σ subunits, strength of the promoters present in the genome and overall regulatory organization.

In *E. coli*, RNAP can use 6S RNA as a template to generate 14--24 nt long *de novo* RNA molecules, named pRNA, originating from the central bulge on the 5′ strand (Wassarman and Saecker, [@B118]; Gildehaus et al., [@B38]). However, transcription from 6S RNA only occurs after a sudden increase in the NTP pool, for example when bacteria in post-exponential phase are diluted with fresh medium. Transcription from 6S RNA leads to the dissociation of 6S RNA from Eσ^70^, which is then free to transcribe genes again. This also causes destabilization of 6S RNA, due to increased access of nucleases to unbound 6S RNA or recognition of the 6S RNA--pRNA duplex by RNases (Wassarman and Saecker, [@B118]). Therefore, synthesis of pRNA seems to be a way to "reset" this regulatory system. Synthesis of pRNA probably also occurs in other bacteria as well, including *L. pneumophila*, but at present direct evidence for this is lacking.

Some bacterial species contain two or more 6S RNA homologs, such as *Bacillus subtilis* and *Clostridium* (Barrick et al., [@B7]; Trotochaud and Wassarman, [@B106]). A second 6S RNA homolog, named 6S2 RNA, was recently identified in the *L. pneumophila* genome (Weissenmayer et al., [@B121]). Surprisingly, the authors could detect transcription from the opposite strand encoding 6S2 RNA and suggest that its expression is regulated by a cis-acting sRNA. The 6S2 RNA is expressed in E and PE phase at a similar level, but the antisense transcript is only expressed in E phase, which could inhibit 6S2 function during E phase and therefore effectively result in functional 6S2 RNA expression only during PE phase. That would result in a situation similar to the 6S RNA of *E. coli* and the 6S RNA of *L. pneumophila* that are only highly expressed in PE phase. The role of 6S2 RNA is currently unknown and it would be interesting to investigate the phenotype of a mutant defective in both 6S RNA and 6S2 RNA.

The CRISPR Immunity System
==========================

The CRISPR loci encode a sRNA-based immunity system against viruses and other invading DNA (Horvath and Barrangou, [@B45]). It consists of a leader sequence followed by several non-contiguous direct repeats separated by pieces of variable sequences called spacers. The spacer is a sequence of DNA (21--72 bp) originating from invading viral or plasmid DNA that has been integrated in the bacterial genome. Following transcription of the CRISPR loci, the multi-repeat, multi-spacer RNA is processed by CRISPR-associated protein (Cas) into small units consisting of a spacer flanked by two partial repeats, called crRNA. Those crRNA provide specificity to the system by guiding the Cas interference machinery to the invading nucleic acids that match its sequence. Therefore, the spacers are remnants of past viral infections or plasmid invasions and can be viewed as a form of acquired immunity. New spacers can be added at the leader end of the CRISPR loci.

In *L. pneumophila*, CRISPR loci have been identified in the Lens, Alcoy, and Paris strains, but not in Philadelphia-1 (D\'Auria et al., [@B26]). The Lens strain possess two CRISPR loci, one on the chromosome, the other on a plasmid. The Alcoy and Lens CRISPR systems are almost identical, composed of three Cas genes (*cas1*, *cas3*, and *csy4*) and 55 or 52 repeats, respectively, of 27 bp with one bp difference between the two strains. The Paris locus are not related to the Alcoy/Lens loci and is composed of *cas1, cas2*, and *cas4* and contains 34 repeats of 37 bp. BLAST analysis of the spacer sequences did not identify any homologous sequences in the GenBank database. It is noteworthy that four bacteriophages of *L. pneumophila* have been identified from environmental water samples, but their sequences are unknown (Lammertyn et al., [@B55]). There is currently no evidence of any implication of the CRISPR system in regulation of virulence-related traits in *L. pneumophila*. However, in *P. aeruginosa*, the CRISPR system is needed for bacteriophage-mediated inhibition of biofilm formation and swarming motility following lysogenic infection with bacteriophage DMS3 (Zegans et al., [@B124]). This suggests that the combination of lysogenic infection and the presence of an active CRISPR system may have an impact on the regulation of group behavior traits. Whether or not this is relevant in the context of host infection by bacterial pathogens still needs to be determined.

Relief of Stalled Ribosomes by tmRNA
====================================

Stalling of ribosomes on a mRNA occurs when the translation machinery reaches the end of of the transcript without encountering a stop codon. This is a consequence of co-transcriptional translation that occurs in bacteria and the translation of mRNA that are being degraded from the 3′ end. Stalling of the ribosome prevents its release from the mRNA and can cause decay of the active ribosome pool. Moreover, generation of incomplete proteins can be toxic to the cells. Therefore, a system is needed to release the ribosome and target the incomplete protein for degradation. This function is performed by the tmRNA that is universally conserved in the bacterial kingdom (reviewed in Keiler, [@B53]; Table [1](#T1){ref-type="table"}). The name tmRNA comes from the two functions performed by this sRNA. It acts as a tRNA and is charged with alanine and it acts as an mRNA, encoding a short peptide tag, which targets a protein for degradation. The current model of tmRNA-mediated rescue of stalled ribosome includes two proteins: SmpB and EF-Tu. A complex formed from alanyl--tmRNA--SmpB--EF-Tu enters the A-site of the stalled ribosome. The nascent protein is transferred to the alanyl--tmRNA. The complex then moves to the P-site and the ribosome translates the short peptide tag encoded on the tmRNA, resulting in tagging of the protein and release of the mRNA. Deletion of tmRNA usually results in strong phenotypes such as a marked reduction in growth rate and lethality (Keiler, [@B53]). In the intracellular pathogen *Salmonella*, deletion of tmRNA or the *smpB* gene results in severe reduction in survival capacity and pathogenesis in mouse macrophages (Julio et al., [@B52]; Ansong et al., [@B4]). The effect of the deletion of tmRNA in *L. pneumophila* is currently unknown but SmpB may be essential for axenic growth since a *smpB* deletion mutant could not be constructed (Charpentier et al., [@B18]).

A Note about 5′ and 3′ Untranslated Regions of mRNA
===================================================

In addition to their coding sequences, mRNAs have two distinct regions that can perform regulatory functions: the 5′UTR and the 3′UTR (Gripenland et al., [@B39]). Both regions can vary greatly in length from only a few, to several hundred bases. Some 5′UTR can adopt different structural states depending on conditions inside cells, including temperature (e.g., thermosensor), pH, and the presence of specific metabolites (Figure [1](#F1){ref-type="fig"}A). Such 5′UTR are called riboswitches. One of the best-known riboswitches regulates transcription of the *prfA* gene, a major virulence regulator of *Listeria monocytogenes*. At low temperatures, the *prfA* 5′UTR adopts a structural state that masks the RBS and thus prevents translation. In contrast, at 37°C, the 5′UTR structure changes, exposing the RBS and allowing translation of the PrfA protein and expression of virulence determinants (Johansson et al., [@B49]). No riboswitches have been identified in *L. pneumophila* as yet. However, temperature is known to affect biofilm formation by *L. pneumophila* (Piao et al., [@B73]). Moreover, optimal growth at high and low temperature requires specific stress response proteins: ClpP and RNase R respectively (Charpentier et al., [@B18]; Li et al., [@B60]). Therefore, one may speculate that RNA thermosensors could be involved in *L. pneumophila* gene regulation to promote growth at extreme temperatures and to form biofilms.

The small nucleotide cyclic di-GMP regulates many biological processes in bacteria, including biofilm formation, motility, and virulence (Hengge, [@B43]). Cyclic di-GMP is produced from two guanosine-5′-triphosphate molecules by diguanylate cyclases (DGC, containing a GGDEF domain) and degraded selectively by phosphosdiesterases containing either EAL or HD-GYP domains (Hengge, [@B43]). Therefore, the quantities and activities of DGC and EAL/HD-GYP enzymes determine the net intracellular concentration of cyclic di-GMP, which may be an integration point for many different signals. Consequently, the mechanism(s) of gene regulation by cyclic di-GMP has been the subject of intense investigation. A new riboswitch class that regulates gene expression by binding to the second messenger cyclic di-GMP was described and found in many different bacterial species (Sudarsan et al., [@B99]). Recently, our lab provided evidence that the cyclic di-GMP signaling pathway of *L. pneumophila* is involved in the regulation of intracellular growth and flagellin synthesis (Levi et al., [@B59]). Given the large number of DGC and EAL/HD-GYP enzymes present in *L. pneumophila* genome, it is tempting to speculate that an, as yet, unidentified riboswitch may play a role in cyclic di-GMP regulatory pathways in *L. pneumophila*. However, no riboswitch has been identified in *L. pneumophila* as yet and it would therefore be interesting to performed a systematic search to identify possible candidate.

In eukaryotes, 3′UTRs are important for the control of translation (Sonenberg and Hinnebusch, [@B93]). The importance of 3′UTR for bacterial gene regulation is currently unclear but probably underestimated. Long overlapping 3′UTRs were identified in *L. monocytogenes* and in *B. subtilis* (Rasmussen et al., [@B77]; Toledo-Arana et al., [@B104]). Such 3′UTRs could affect the stability of convergent genes by a mechanism similar to cis-encoded base-pairing sRNAs (see below). Whole-genome tiling array experiments were used to find transcriptionally active regions in *B. subtilis*, which identified a group of genes with long (∼200 nt) homologous 3′UTR (Rasmussen et al., [@B77]). Structure predictions revealed that those 3′UTR fold into a highly stable Y-shaped double-stranded structure ending with a very short single-stranded tail. The author suggested that such structures could target the mRNA to a location in the cells were the protein is needed (i.e., the membrane) or prevent access of RNAses to the 3′ end of the transcript. Stable structures at the 3′ end of mRNAs block the activities of most 3′-exoribonucleases. RNase R is able to degrade double-stranded RNA molecules but needs a single-stranded tail of at least 10 nt (Vincent and Deutscher, [@B110]). In *L. pneumophila*, six actively transcribed 3′UTRs were identified (Table [1](#T1){ref-type="table"}), ranging from 66 to 180 bases (Faucher et al., [@B30]). Whether or not they are involved in gene regulation requires clarification. Interestingly, the predicted structure of *gltX-3*′*UTR* is similar to the Y-shape structure reported in *B. subtilis* homologous 3′UTRs.

The Next Step: Target Identification and Characterization of *L. pneumophila* sRNAs
===================================================================================

Now that a number of actively transcribed sRNAs have been identified in *L. pneumophila*, further research should focus on the determination of their functions and their specific targets. First of all, it is important to define what a true target is. Essentially, a true target is a mRNA or a protein that physically interacts with the sRNA and whose function, stability or translation is affected by this interaction (Vogel and Wagner, [@B113]). The inferred targets of cis-encoded base-pairing sRNAs are obvious, they are the mRNA encoded on the complementary strand. However, even in this case, molecular evidence is needed to establish the link between the two molecules and the effect of the sRNA on the target mRNA. For trans-encoded base-pairing sRNAs, there are *a priori* no indications of what the target might be. As a start, it could be useful to use a bioinformatic approach to generate a list of putative targets that can then be tested experimentally. Target prediction usually relies on the estimation of optimal hybridization scores between sRNA and mRNA targets and often includes the effects of stable secondary structures. Many web servers are available for genome-wide prediction of mRNA targets, including, but not limited to sRNATarget (Cao et al., [@B14]) and TargetRNA (Tjaden et al., [@B103]).

Target prediction could also be used in conjunction with experimental genome-wide approaches such as transcriptional profiling. Comparison of the transcription profile of a mutant strain or an over-expresser strain to the wild-type strain can highlight putative targets (Papenfort et al., [@B70]). One has to keep in mind that any observed effects on transcript expression could be indirect, when, for example, a transcriptional regulator is the true target. Since the effect of some sRNAs can only be seen at the protein level, the effect of a sRNA is not necessarily observable at the steady-state RNA level. Comparison at the proteome level, by 2D gel analysis, could be more informative, but because of detection limitation, poorly expressed proteins are usually missed. Comparison of the sRNA deletion mutant, the over-expresser strain and the wild-type strain by SDS-PAGE and Coomassie staining may be sufficient to suggest a putative target. Then, a protein of interest can be identified by mass spectrometry analysis. The target of the GlmY sRNA, a polycistronic mRNA encoding *glmUS*, was identified with this strategy (Urban et al., [@B108]).

A more direct approach to find the mRNA target of trans-encoded sRNA is to use the sRNA as a bait to fish out the target. In the case of a sRNA that interact with Hfq, the sRNA--Hfq complex can be preloaded into an affinity purification column and incubated with extracted mRNA. After washing, the eluted mRNA are converted to cDNA and identified by sequencing or by microarray analysis. Such method was used to identify the target of the *E. coli* RydC sRNA, an ATP-binding cassette permease (Antal et al., [@B5]). Alternatively, a sRNA could be tagged with biotin, bound to streptavidin--coated magnetic beads and incubated with extracted mRNA. Identification of the captured mRNA could be performed as explained above. This method has been used to identify two targets, *ompA* and *ompC* mRNA, of the RseX sRNA of *E. coli* (Douchin et al., [@B29]).

The identification of protein targets of protein-binding sRNAs is somewhat similar to what was described above for mRNA-binding sRNAs. However, in this case, secondary structures are often very well conserved, which is illustrated by 6S RNA and the CsrB homologs, and therefore structure predictions could serve as a guide. Then proteomic studies could be undertaken or more direct approaches, such as the streptavidin-binding aptamer tag described above could be used (Windbichler et al., [@B122]). Said et al. ([@B82]) have performed a systematic analysis of the use of different aptamers and configurations to identify protein targets of sRNA.

Concluding Remarks
==================

Increasing evidence points to important and broad implications of sRNAs in the regulation of life cycles, stress responses and virulence properties of several pathogenic bacteria (Papenfort and Vogel, [@B71]). This is evident in *L. pneumophila* where three sRNAs, 6S RNA, RsmY, and RsmZ, are already known as major determinants of virulence regulation. However, this is probably only the tip of the iceberg and it is likely that other sRNAs are involved in regulation of virulence and other traits such as biofilm formation and the responses to environmental stresses. In the near future, important goals for characterizing the specific roles of sRNA in *L. pneumophila* biology are the identification of sRNA targets and determining the phenotypes of mutant that are defective in the production of individual and multiple sRNA species.
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